United States· US:24208-629_a4c88d72-eb17-446a-9da5-6bcf1263377f

Bepreve

A medicinal product containing bepotastine besylate, registered in United States by Bausch & Lomb Incorporated.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBepreveATC—REGISTER NO.US:24208-629_a4c88d72…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BEPOTASTINE BESYLATE
Manufacturer
Bausch & Lomb Incorporated
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    24208-629-01
  • ndc11
    24208-629-02
  • ndc11
    24208-629-03
  • ndc11
    2420862901
    1 BOTTLE, DROPPER in 1 CARTON (24208-629-01) / 10 mL in 1 BOTTLE, DROPPER
  • ndc11
    2420862902
    1 BOTTLE, DROPPER in 1 CARTON (24208-629-02) / 5 mL in 1 BOTTLE, DROPPER
  • ndc11
    2420862903
    1 BOTTLE, DROPPER in 1 CARTON (24208-629-03) / 1 mL in 1 BOTTLE, DROPPER

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bepotastine besylate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bepotastine besylate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9c924a9d-359b-4d6d-bbc5-0120084ddc61
GET /v1/drugs/9c924a9d-359b-4d6d-bbc5-0120084ddc61?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": "15",
  "substance": "BEPOTASTINE BESYLATE",
  "productndc": "24208-629",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA022288",
  "marketing_category": "NDA"
}

See everything about bepotastine besylate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.